Metformin ameliorates experimental diabetic periodontitis independently of mammalian target of rapamycin (mTOR) inhibition by reducing NIMA-related kinase 7(Nek7) expression
Journal of Periodontology Apr 11, 2019
Zhou X, et al. - Data were estimated to delineate the anti-inflammatory outcomes of metformin on the NIMA-related kinase 7(Nek7)/NOD-like receptor family pyrin domain containing 3 (NLRP3) pathway both in vivo and in vitro in diabetic periodontitis cases. They observed a significant attenuation of experimental diabetic periodontitis with metformin, both in vivo and in vitro. They noted that metformin suppressed the inflammatory state by hindering the Nek7 expression to reduce NLRP3 inflammasome activity. They did not report the role of mTOR inhibition in metformin-induced Nek7 downregulation. They suggested a relation of observed Nek7 reduction with metformin-mediated cell cycle arrest.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries